Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Mologen announces results from extension phase of TEACH study of lefitolimod in HIV

Aug. 10, 2017

GlaxoSmithKline patents HIV maturation inhibitors

Aug. 9, 2017

Mylan receives PEPFAR tentative approval for TLD fixed-dose combination regimen

Aug. 8, 2017

Janssen reports results of APPROACH study of Ad26.Mos.HIV HIV-1 vaccine regimens

Aug. 8, 2017

The PS externalization pathway as a potential new target for the development of anti-HIV-1 therapies

Aug. 7, 2017

Dolutegravir superior in combination with NRTIs for treating HIV-1 infection

Aug. 4, 2017

Sichuan Haisco Pharmaceutical divulges new antivirals

Aug. 4, 2017

Phase III trial shows HIV suppression with bictegravir/emtricitabine/tenofovir coformulation

Aug. 2, 2017

Phase II data from IPROTECT1 trial presented for VAC-3S anti-HIV1 vaccine

Aug. 2, 2017

Aelix conducts phase I trial of DNA.HTI and MVA.HTI in HIV-1-positive patients

July 27, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...